India's Biotechnology Market : A Booming Sector
Explore India’s rapidly expanding biotechnology market, projected to reach $300 billion by 2030, driven by strategic investments, supportive government policies, and a thriving startup ecosystem. This is your chance to invest in the future of biotech!
Investment Opportunities in India's Biotech Sector
FDI Incentives
Benefit from 100% FDI under the automatic route for greenfield projects and 74% for brownfield investments. Government approval allows 100% FDI in brownfield projects.
Financial Support
Take advantage of the Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE) scheme with $1.1 billion allocated for 2021-2026.
National Biopharma Mission
Support for over 101 projects, 150+ organizations, and 30 MSMEs, creating jobs and advancing biotech research.
Global Investments Fueling India's Biotech Growth
Bristol-Myers Squibb
$97M investment in a Medical R&D facility in Telangana.
IPL Biologicals
$48M investment in a Bio-fertilizer facility in Gujarat.
Aurigene
$40M investment in a Hyderabad biotech facility.
Strategic Partnerships
Collaborative ventures boosting vaccine manufacturing and research.
Key Growth Drivers in India's Biotechnology Industry
Biopharma Leadership
Biopharma and medical devices contribute 79% of India's bio-economy. The vaccine market is expected to reach $3.04 billion by 2025.
Biosimilars and Regenerative Medicine
India has over 125 approved biosimilars, with the market expected to reach $2.2 billion by 2025. Stem cell research is expanding with government support.
Biotech Start-Up Ecosystem
India has 6,500+ biotech start-ups, projected to reach 10,000 by 2025, supported by 75 bio-incubators across 21 states.
Government Support for Biotechnology Growth
Production Linked Incentive (PLI) Scheme
Financial support to boost biopharmaceutical manufacturing and R&D, enhancing India's global competitiveness.
Biotech Parks Initiative
A network of 11 state-of-the-art biotechnology parks across India supporting SMEs and research institutes.
State-Specific Biotechnology Policies
Strategic policies by states like Karnataka, Gujarat, and Telangana to establish specialized biotech hubs.
India's Role in Global Supply Chains
FDA-Approved Plants
India has 665 US FDA-approved pharma and biotech plants, the highest outside the US.
ANDA Share
The country holds a 44% share of global Abbreviated New Drug Applications (ANDA).
Bio-IT Growth
Bioinformatics and AI-driven biotech solutions are emerging as high-growth areas.
Invest in India's Biotechnology Market
Fast-Growing Bio-Economy
Projected to reach $300 billion by 2030.
Vaccine and Biosimilar Leader
A global hub for vaccines and biosimilars production.
Strong Government Support
100% FDI, R&D incentives, and biotech-specific policies.
High Clinical Trial Demand
$3.2 billion market size with increasing foreign collaboration.
